TY - JOUR AU - Hamamoto, R. AU - Saloura, V. AU - Nakamura, Y. PY - 2015 DA - 2015// TI - Critical roles of non-histone protein lysine methylation in human tumorigenesis JO - Nat Rev Cancer VL - 15 UR - https://doi.org/10.1038/nrc3884 DO - 10.1038/nrc3884 ID - Hamamoto2015 ER - TY - JOUR AU - Gao, J. AU - Aksoy, B. A. AU - Dogrusoz, U. PY - 2013 DA - 2013// TI - Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal JO - Sci Signal VL - 6 UR - https://doi.org/10.1126/scisignal.2004088 DO - 10.1126/scisignal.2004088 ID - Gao2013 ER - TY - JOUR AU - Cerami, E. AU - Gao, J. AU - Dogrusoz, U. PY - 2012 DA - 2012// TI - The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data JO - Cancer Discov VL - 2 UR - https://doi.org/10.1158/2159-8290.CD-12-0095 DO - 10.1158/2159-8290.CD-12-0095 ID - Cerami2012 ER - TY - JOUR AU - Guo, S. AU - Li, X. AU - Rohr, J. PY - 2016 DA - 2016// TI - EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features JO - Diagn Pathol VL - 11 UR - https://doi.org/10.1186/s13000-016-0491-5 DO - 10.1186/s13000-016-0491-5 ID - Guo2016 ER - TY - JOUR AU - Kleer, C. G. AU - Cao, Q. AU - Varambally, S. PY - 2003 DA - 2003// TI - EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells JO - Proc Natl Acad Sci U S A VL - 100 UR - https://doi.org/10.1073/pnas.1933744100 DO - 10.1073/pnas.1933744100 ID - Kleer2003 ER - TY - JOUR AU - Bachmann, I. M. AU - Halvorsen, O. J. AU - Collett, K. PY - 2006 DA - 2006// TI - EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.01.5180 DO - 10.1200/JCO.2005.01.5180 ID - Bachmann2006 ER - TY - JOUR AU - Dong, M. AU - Fan, X. J. AU - Chen, Z. H. PY - 2014 DA - 2014// TI - Aberrant expression of enhancer of zeste homologue 2, correlated with HIF-1α, refines relapse risk and predicts poor outcome for breast cancer JO - Oncol Rep VL - 32 UR - https://doi.org/10.3892/or.2014.3322 DO - 10.3892/or.2014.3322 ID - Dong2014 ER - TY - JOUR AU - Lv, Y. AU - Yuan, C. AU - Xiao, X. PY - 2012 DA - 2012// TI - The expression and significance of the enhancer of zeste homolog 2 in lung adenocarcinoma JO - Oncol Rep VL - 28 UR - https://doi.org/10.3892/or.2012.1787 DO - 10.3892/or.2012.1787 ID - Lv2012 ER - TY - JOUR AU - Kikuchi, J. AU - Kinoshita, I. AU - Shimizu, Y. PY - 2010 DA - 2010// TI - Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.25128 DO - 10.1002/cncr.25128 ID - Kikuchi2010 ER - TY - JOUR AU - Behrens, C. AU - Solis, L. M. AU - Lin, H. PY - 2013 DA - 2013// TI - EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432 DO - 10.1158/1078-0432 ID - Behrens2013 ER - TY - JOUR AU - Wang, C. G. AU - Ye, Y. J. AU - Yuan, J. PY - 2010 DA - 2010// TI - EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis JO - World J Gastroenterol VL - 16 UR - https://doi.org/10.3748/wjg.v16.i19.2421 DO - 10.3748/wjg.v16.i19.2421 ID - Wang2010 ER - TY - JOUR AU - Chen, Z. AU - Yang, P. AU - Li, W. PY - 2018 DA - 2018// TI - Expression of EZH2 is associated with poor outcome in colorectal cancer JO - Oncol Lett VL - 15 UR - https://doi.org/10.3892/ol.2017.7647 DO - 10.3892/ol.2017.7647 ID - Chen2018 ER - TY - JOUR AU - Ohuchi, M. AU - Sakamoto, Y. AU - Tokunaga, R. PY - 2018 DA - 2018// TI - Increased EZH2 expression during the adenoma-carcinoma sequence in colorectal cancer JO - Oncol Lett VL - 16 UR - https://doi.org/10.3892/ol.2018.9240 DO - 10.3892/ol.2018.9240 ID - Ohuchi2018 ER - TY - JOUR AU - Vilorio-Marqués, L. AU - Martín, V. AU - Diez-Tascón, C. AU - González-Sevilla, M. F. AU - Fernández-Villa, T. AU - Honrado, E. PY - 2017 DA - 2017// TI - The role of EZH2 in overall survival of colorectal cancer: a meta-analysis JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-13670-z DO - 10.1038/s41598-017-13670-z ID - Vilorio-Marqués2017 ER - TY - JOUR AU - Deb, G. AU - Singh, A. K. AU - Gupta, S. PY - 2014 DA - 2014// TI - EZH2: not EZHY (easy) to deal JO - Mol Cancer Res VL - 12 UR - https://doi.org/10.1158/1541-7786.MCR-13-0546 DO - 10.1158/1541-7786.MCR-13-0546 ID - Deb2014 ER - TY - JOUR AU - Zhou, J. AU - Roh, J. W. AU - Bandyopadhyay, S. PY - 2013 DA - 2013// TI - Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) in high grade endometrial carcinoma JO - Gynecol Oncol VL - 128 UR - https://doi.org/10.1016/j.ygyno.2012.07.128 DO - 10.1016/j.ygyno.2012.07.128 ID - Zhou2013 ER - TY - JOUR AU - Oki, S. AU - Sone, K. AU - Oda, K. PY - 2017 DA - 2017// TI - Oncogenic histone methyltransferase EZH2: a novel prognostic marker with therapeutic potential in endometrial cancer JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.16316 DO - 10.18632/oncotarget.16316 ID - Oki2017 ER - TY - JOUR AU - He, L. J. AU - Cai, M. Y. AU - Xu, G. L. PY - 2012 DA - 2012// TI - Prognostic significance of overexpression of EZH2 and H3k27me3 proteins in gastric cancer JO - Asian Pac J Cancer Prev VL - 13 UR - https://doi.org/10.7314/apjcp.2012.13.7.3173 DO - 10.7314/apjcp.2012.13.7.3173 ID - He2012 ER - TY - JOUR AU - Varambally, S. AU - Dhanasekaran, S. M. AU - Zhou, M. PY - 2002 DA - 2002// TI - The polycomb group protein EZH2 is involved in progression of prostate cancer JO - Nature VL - 419 UR - https://doi.org/10.1038/nature01075 DO - 10.1038/nature01075 ID - Varambally2002 ER - TY - JOUR AU - Rao, Z. Y. AU - Cai, M. Y. AU - Yang, G. F. PY - 2010 DA - 2010// TI - EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients JO - Carcinogenesis VL - 31 UR - https://doi.org/10.1093/carcin/bgq150 DO - 10.1093/carcin/bgq150 ID - Rao2010 ER - TY - JOUR AU - Li, H. AU - Cai, Q. AU - Godwin, A. K. PY - 2010 DA - 2010// TI - Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells JO - Mol Cancer Res VL - 8 UR - https://doi.org/10.1158/1541-7786.MCR-10-0398 DO - 10.1158/1541-7786.MCR-10-0398 ID - Li2010 ER - TY - JOUR AU - Kidani, K. AU - Osaki, M. AU - Tamura, T. PY - 2009 DA - 2009// TI - High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas JO - Oral Oncol VL - 45 UR - https://doi.org/10.1016/j.oraloncology.2008.03.016 DO - 10.1016/j.oraloncology.2008.03.016 ID - Kidani2009 ER - TY - JOUR AU - Cao, W. AU - Feng, Z. AU - Cui, Z. PY - 2012 DA - 2012// TI - Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma JO - Cancer VL - 118 UR - https://doi.org/10.1002/cncr.26575 DO - 10.1002/cncr.26575 ID - Cao2012 ER - TY - JOUR AU - Wang, C. AU - Liu, X. AU - Chen, Z. PY - 2013 DA - 2013// TI - Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma JO - Mol Carcinog VL - 52 UR - https://doi.org/10.1002/mc.21848 DO - 10.1002/mc.21848 ID - Wang2013 ER - TY - JOUR AU - Chen, M. W. AU - Hua, K. T. AU - Kao, H. J. PY - 2010 DA - 2010// TI - H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-10-0833 DO - 10.1158/0008-5472.CAN-10-0833 ID - Chen2010 ER - TY - JOUR AU - Zhang, K. AU - Wang, J. AU - Yang, L. PY - 2018 DA - 2018// TI - Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer JO - Mol Cancer VL - 17 UR - https://doi.org/10.1186/s12943-018-0896-8 DO - 10.1186/s12943-018-0896-8 ID - Zhang2018 ER - TY - JOUR AU - Hu, L. AU - Zang, M. D. AU - Wang, H. X. PY - 2018 DA - 2018// TI - G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner JO - Cell Death Dis VL - 9 UR - https://doi.org/10.1038/s41419-018-0322-6 DO - 10.1038/s41419-018-0322-6 ID - Hu2018 ER - TY - JOUR AU - Bai, K. AU - Cao, Y. AU - Huang, C. PY - 2016 DA - 2016// TI - Association of histone methyltransferase G9a and overall survival after liver resection of patients with hepatocellular carcinoma with a median observation of 40 months JO - Medicine (Baltimore) VL - 95 UR - https://doi.org/10.1097/MD.0000000000002493 DO - 10.1097/MD.0000000000002493 ID - Bai2016 ER - TY - JOUR AU - Hua, K. T. AU - Wang, M. Y. AU - Chen, M. W. PY - 2014 DA - 2014// TI - The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis JO - Mol Cancer VL - 13 UR - https://doi.org/10.1186/1476-4598-13-189 DO - 10.1186/1476-4598-13-189 ID - Hua2014 ER - TY - JOUR AU - Li, K. C. AU - Hua, K. T. AU - Lin, Y. S. PY - 2014 DA - 2014// TI - Inhibition of G9a induces DUSP4-dependent autophagic cell death in head and neck squamous cell carcinoma JO - Mol Cancer VL - 15 UR - https://doi.org/10.1186/1476-4598-13-172 DO - 10.1186/1476-4598-13-172 ID - Li2014 ER - TY - JOUR AU - Komatsu, S. AU - Ichikawa, D. AU - Hirajima, S. PY - 2015 DA - 2015// TI - Overexpression of SMYD2 contributes to malignant outcome in gastric cancer JO - Br J Cancer VL - 112 UR - https://doi.org/10.1038/bjc.2014.543 DO - 10.1038/bjc.2014.543 ID - Komatsu2015 ER - TY - JOUR AU - Zuo, S. R. AU - Zuo, X. C. AU - He, Y. PY - 2018 DA - 2018// TI - Positive expression of SMYD2 is associated with poor prognosis in patients with primary hepatocellular carcinoma JO - J Cancer VL - 9 UR - https://doi.org/10.7150/jca.22218 DO - 10.7150/jca.22218 ID - Zuo2018 ER - TY - JOUR AU - Fei, X. AU - Ma, Y. AU - Liu, X. PY - 2017 DA - 2017// TI - Overexpression of SMYD3 is predictive of unfavorable prognosis in hepatocellular carcinoma JO - Tohoku J Exp Med VL - 243 UR - https://doi.org/10.1620/tjem.243.219 DO - 10.1620/tjem.243.219 ID - Fei2017 ER - TY - JOUR AU - Lobo, J. AU - Rodrigues, A. AU - Antunes, L. PY - 2018 DA - 2018// TI - High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer JO - Urol Oncol VL - 36 UR - https://doi.org/10.1016/j.urolonc.2017.10.028 DO - 10.1016/j.urolonc.2017.10.028 ID - Lobo2018 ER - TY - JOUR AU - Xiao, M. AU - Yang, S. AU - Chen, J. PY - 2013 DA - 2013// TI - Overexpression of MMSET in endometrial cancer: a clinicopathologic study JO - J Surg Oncol VL - 107 UR - https://doi.org/10.1002/jso.23234 DO - 10.1002/jso.23234 ID - Xiao2013 ER - TY - JOUR AU - Li, N. AU - Xue, W. AU - Yuan, H. PY - 2017 DA - 2017// TI - AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis JO - J Clin Invest VL - 127 UR - https://doi.org/10.1172/JCI91144 DO - 10.1172/JCI91144 ID - Li2017 ER - TY - JOUR AU - Saloura, V. AU - Cho, H. S. AU - Kiyotani, K. PY - 2015 DA - 2015// TI - WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck JO - Mol Cancer Res VL - 13 UR - https://doi.org/10.1158/1541-7786.MCR-14-0292-T DO - 10.1158/1541-7786.MCR-14-0292-T ID - Saloura2015 ER - TY - JOUR AU - Saloura, V. AU - Vougiouklakis, T. AU - Zewde, M. PY - 2016 DA - 2016// TI - WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.9897 DO - 10.18632/oncotarget.9897 ID - Saloura2016 ER - TY - JOUR AU - Zhang, Y. AU - Liu, J. AU - Lin, J. PY - 2016 DA - 2016// TI - The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.7126 DO - 10.18632/oncotarget.7126 ID - Zhang2016 ER - TY - JOUR AU - Chen, Y. AU - Yang, S. AU - Hu, J. PY - 2016 DA - 2016// TI - Increased expression of SETD7 promotes cell proliferation by regulating cell cycle and indicates poor prognosis in hepatocellular carcinoma JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0154939 DO - 10.1371/journal.pone.0154939 ID - Chen2016 ER - TY - JOUR AU - Zhu, Y. AU - Bai, K. AU - Yu, J. PY - 2016 DA - 2016// TI - Association between histone methyltransferase hSETD1A and prognosis in patients with triple-negative breast cancer after surgery: a retrospective study in the Chinese female population JO - Medicine (Baltimore) VL - 95 UR - https://doi.org/10.1097/MD.0000000000003783 DO - 10.1097/MD.0000000000003783 ID - Zhu2016 ER - TY - JOUR AU - Ho, Y. J. AU - Lin, Y. M. AU - Huang, Y. C. PY - 2017 DA - 2017// TI - Significance of histone methyltransferase SETDB1 expression in colon adenocarcinoma JO - APMIS VL - 125 UR - https://doi.org/10.1111/apm.12745 DO - 10.1111/apm.12745 ID - Ho2017 ER - TY - JOUR AU - Chen, K. AU - Zhang, F. AU - Ding, J. PY - 2017 DA - 2017// TI - Histone methyltransferase SETDB1 promotes the progression of colorectal cancer by inhibiting the expression of TP53 JO - J Cancer VL - 8 UR - https://doi.org/10.7150/jca.20482 DO - 10.7150/jca.20482 ID - Chen2017 ER - TY - JOUR AU - Fei, Q. AU - Shang, K. AU - Zhang, J. PY - 2015 DA - 2015// TI - Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53 JO - Nat Commun VL - 6 UR - https://doi.org/10.1038/ncomms9651 DO - 10.1038/ncomms9651 ID - Fei2015 ER - TY - JOUR AU - Wong, C. M. AU - Wei, L. AU - Law, C. T. PY - 2016 DA - 2016// TI - Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis JO - Hepatology VL - 63 UR - https://doi.org/10.1002/hep.28304 DO - 10.1002/hep.28304 ID - Wong2016 ER - TY - JOUR AU - Yang, Y. AU - Shen, J. AU - Yan, D. PY - 2018 DA - 2018// TI - Euchromatic histone lysine methyltransferase 1 regulates cancer development in human gastric cancer by regulating E-cadherin JO - Oncol Lett VL - 15 UR - https://doi.org/10.3892/ol.2018.8506 DO - 10.3892/ol.2018.8506 ID - Yang2018 ER - TY - JOUR AU - Li, S. AU - Shen, L. AU - Chen, K. N. PY - 2018 DA - 2018// TI - Association between H3K4 methylation and cancer prognosis: a meta-analysis JO - Thorac Cancer VL - 9 UR - https://doi.org/10.1111/1759-7714.12647 DO - 10.1111/1759-7714.12647 ID - Li2018 ER - TY - JOUR AU - Seligson, D. B. AU - Horvath, S. AU - McBrian, M. A. PY - 2009 DA - 2009// TI - Global levels of histone modifications predict prognosis in different cancers JO - Am J Pathol VL - 174 UR - https://doi.org/10.2353/ajpath.2009.080874 DO - 10.2353/ajpath.2009.080874 ID - Seligson2009 ER - TY - JOUR AU - Seligson, D. B. AU - Horvath, S. AU - Shi, T. AU - Yu, H. AU - Tze, S. AU - Grunstein, M. AU - Kurdistani, S. K. PY - 2005 DA - 2005// TI - Global histone modification patterns predict risk of prostate cancer recurrence JO - Nature VL - 435 UR - https://doi.org/10.1038/nature03672 DO - 10.1038/nature03672 ID - Seligson2005 ER - TY - JOUR AU - Benard, A. AU - Goossens-Beumer, I. J. AU - Hoesel, A. Q. PY - 2014 DA - 2014// TI - Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer JO - BMC Cancer VL - 14 UR - https://doi.org/10.1186/1471-2407-14-531 DO - 10.1186/1471-2407-14-531 ID - Benard2014 ER - TY - JOUR AU - He, C. AU - Xu, J. AU - Zhang, J. PY - 2012 DA - 2012// TI - High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma JO - Hum Pathol VL - 43 UR - https://doi.org/10.1016/j.humpath.2011.11.003 DO - 10.1016/j.humpath.2011.11.003 ID - He2012 ER - TY - JOUR AU - Fornaro, L. AU - Faviana, P. AU - Gregorio, V. PY - 2015 DA - 2015// TI - Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1889-2 DO - 10.1186/s12885-015-1889-2 ID - Fornaro2015 ER - TY - JOUR AU - Cai, M. Y. AU - Hou, J. H. AU - Rao, H. L. PY - 2011 DA - 2011// TI - High expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients JO - Mol Med VL - 17 UR - https://doi.org/10.2119/molmed.2010.00103 DO - 10.2119/molmed.2010.00103 ID - Cai2011 ER - TY - JOUR AU - Lin, S. AU - Zhou, M. AU - Li, Y. PY - 2019 DA - 2019// TI - H3K27 trimethylation and H3K9 dimethylation as poor prognostic markers for patients with esophageal squamous cell carcinoma JO - Int J Clin Exp Pathol VL - 12 ID - Lin2019 ER - TY - JOUR AU - Liu, F. AU - Gu, L. AU - Cao, Y. PY - 2016 DA - 2016// TI - Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients JO - Biomarkers VL - 21 UR - https://doi.org/10.3109/1354750X.2015.1118537 DO - 10.3109/1354750X.2015.1118537 ID - Liu2016 ER - TY - JOUR AU - Li, Y. AU - Guo, D. AU - Sun, R. PY - 2019 DA - 2019// TI - Methylation patterns of Lys9 and Lys27 on histone H3 correlate with patient outcome in gastric cancer JO - Dig Dis Sci VL - 64 UR - https://doi.org/10.1007/s10620-018-5341-8 DO - 10.1007/s10620-018-5341-8 ID - Li2019 ER - TY - JOUR AU - Holm, K. AU - Grabau, D. AU - Lövgren, K. PY - 2012 DA - 2012// TI - Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes JO - Mol Oncol VL - 6 UR - https://doi.org/10.1016/j.molonc.2012.06.002 DO - 10.1016/j.molonc.2012.06.002 ID - Holm2012 ER - TY - JOUR AU - Healey, M. A. AU - Hu, R. AU - Beck, A. H. PY - 2014 DA - 2014// TI - Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the nurses’ health study JO - Breast Cancer Res Treat VL - 147 UR - https://doi.org/10.1007/s10549-014-3089-1 DO - 10.1007/s10549-014-3089-1 ID - Healey2014 ER - TY - JOUR AU - Chen, X. AU - Song, N. AU - Matsumoto, K. PY - 2013 DA - 2013// TI - High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer JO - Int J Oncol VL - 43 UR - https://doi.org/10.3892/ijo.2013.2062 DO - 10.3892/ijo.2013.2062 ID - Chen2013 ER - TY - JOUR AU - Lien, H. C. AU - Jeng, Y. M. AU - Jhuang, Y. L. AU - Yuan, R. H. PY - 2018 DA - 2018// TI - Increased Trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma JO - PLoS One VL - 13 UR - https://doi.org/10.1371/journal.pone.0206261 DO - 10.1371/journal.pone.0206261 ID - Lien2018 ER - TY - JOUR AU - Ho, T. H. AU - Kapur, P. AU - Joseph, R. W. PY - 2016 DA - 2016// TI - Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death JO - Mod Pathol VL - 29 UR - https://doi.org/10.1038/modpathol.2015.123 DO - 10.1038/modpathol.2015.123 ID - Ho2016 ER - TY - JOUR AU - Yokoyama, Y. AU - Hieda, M. AU - Nishioka, Y. PY - 2013 DA - 2013// TI - Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo JO - Cancer Sci VL - 104 UR - https://doi.org/10.1111/cas.12166 DO - 10.1111/cas.12166 ID - Yokoyama2013 ER - TY - JOUR AU - Park, Y. S. AU - Jin, M. Y. AU - Kim, Y. J. PY - 2008 DA - 2008// TI - The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma JO - Ann Surg Oncol VL - 15 UR - https://doi.org/10.1245/s10434-008-9927-9 DO - 10.1245/s10434-008-9927-9 ID - Park2008 ER - TY - JOUR AU - Song, J. S. AU - Kim, Y. S. AU - Kim, D. K. AU - Park, S. I. AU - Jang, S. J. PY - 2012 DA - 2012// TI - Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients JO - Pathol Int VL - 62 UR - https://doi.org/10.1111/j.1440-1827.2011.02776.x DO - 10.1111/j.1440-1827.2011.02776.x ID - Song2012 ER - TY - JOUR AU - Zhou, M. AU - Li, Y. AU - Lin, S. PY - 2019 DA - 2019// TI - H3K9me3, H3K36me3, and H4K20me3 expression correlates with patient outcome in esophageal squamous cell carcinoma as epigenetic markers JO - Dig Dis Sci VL - 64 UR - https://doi.org/10.1007/s10620-019-05529-2 DO - 10.1007/s10620-019-05529-2 ID - Zhou2019 ER - TY - JOUR AU - Fontebasso, A. M. AU - Schwartzentruber, J. AU - Khuong-Quang, D. A. PY - 2013 DA - 2013// TI - Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas JO - Acta Neuropathol VL - 125 UR - https://doi.org/10.1007/s00401-013-1095-8 DO - 10.1007/s00401-013-1095-8 ID - Fontebasso2013 ER - TY - JOUR AU - Copeland, R. A. PY - 2018 DA - 2018// TI - Protein methyltransferase inhibitors as precision cancer therapeutics: a decade of discovery JO - Philos Trans R Soc Lond Ser B Biol Sci VL - 373 UR - https://doi.org/10.1098/rstb.2017.0080 DO - 10.1098/rstb.2017.0080 ID - Copeland2018 ER - TY - JOUR AU - Kaniskan, H. Ü. AU - Martini, M. L. AU - Jin, J. PY - 2018 DA - 2018// TI - Inhibitors of protein Methyltransferases and Demethylases JO - Chem Rev VL - 118 UR - https://doi.org/10.1021/acs.chemrev.6b00801 DO - 10.1021/acs.chemrev.6b00801 ID - Kaniskan2018 ER - TY - BOOK PY - 2020 DA - 2020// TI - Bethesda (MD): National Library of medicine (US) ID - ref69 ER - TY - JOUR AU - Italiano, A. AU - Soria, J. C. AU - Toulmonde, M. PY - 2018 DA - 2018// TI - Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study JO - Lancet Oncol VL - 19 UR - https://doi.org/10.1016/S1470-2045(18)30145-1 DO - 10.1016/S1470-2045(18)30145-1 ID - Italiano2018 ER - TY - JOUR AU - Zauderer, M. G. AU - Szlosarek, P. AU - Moulec, S. PY - 2018 DA - 2018// TI - Phase 2, multicenter study of the EZH2 inhibitor tazemetostat as monotherapy in adults with relapsed or refractory (R/R) malignant mesothelioma (MM) with BAP1 inactivation JO - J Clin Oncol VL - 36 UR - https://doi.org/10.1200/JCO.2018.36.15_suppl.8515 DO - 10.1200/JCO.2018.36.15_suppl.8515 ID - Zauderer2018 ER - TY - JOUR AU - Gan, L. AU - Yang, Y. AU - Li, Q. PY - 2018 DA - 2018// TI - Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential JO - Biomark Res VL - 6 UR - https://doi.org/10.1186/s40364-018-0122-2 DO - 10.1186/s40364-018-0122-2 ID - Gan2018 ER - TY - STD TI - Cancer Staging. National Cancer Institute. https://www.cancer.gov/about-cancer/diagnosis-staging/staging. Published March 9, 2015. Accessed 20 Apr 2020. UR - https://www.cancer.gov/about-cancer/diagnosis-staging/staging ID - ref73 ER - TY - STD TI - Prostate Cancer Screening. National Cancer Institute. https://www.cancer.gov/types/prostate/patient/prostate-screening-pdq. Updated April 10, 2019. Accessed 0 Apr 2020. UR - https://www.cancer.gov/types/prostate/patient/prostate-screening-pdq ID - ref74 ER - TY - STD TI - FIGO Staging of Gynecologic Tumors. National Cancer Institute. https://training.seer.cancer.gov/staging/systems/schemes/figo.html. Accessed 20 Apr 2020. UR - https://training.seer.cancer.gov/staging/systems/schemes/figo.html ID - ref75 ER -